International Precision Medicine Tech Co. LLC. has established strategic partnerships with world-leading research institutions and companies to drive groundbreaking progress in the field of medicine.

A nonprofit research institute in the United States specializing in translational genomics research, aiming to advance medicine through genomics and other molecular biology technologies.

TGen (Translational Genomics Research Institute), established in 2002 and headquartered in Phoenix, Arizona, operates a 170,000-square-foot state-of-the-art research facility along with four additional offices. TGen's mission is to advance precision medicine by leveraging cutting-edge laboratory tools, diagnostic methods, and data analysis. The institute focuses on developing treatments for cancer, pediatric leukemia, and Parkinson's disease, positioning itself as a recognized leader in these fields.

A genetic testing center leveraging computer science, analytics, and data management methodologies

Fulgent Genetics operates CAP and CLIA-certified genetic laboratories, offering genetic testing for over 5,700 conditions/phenotypes and more than 19,300 genes. It is ranked as the #1 laboratory by the NIH based on the number of tests provided in the Gene Testing Registry. The company provides a range of services, including clinical genetics and genomics testing, research sequencing services, and consumer clinical genetics solutions.

Dedicated to promoting medical exchange between China and the United States and advancing the development of precision medicine

The Society of Chinese American Physician Entrepreneurs (SCAPE), founded in 2014, is dedicated to fostering medical exchange and collaboration between China and the United States. As a multidisciplinary and cross-professional medical organization, SCAPE brings together Chinese-American physicians from across North America to advance precision medicine. By establishing an international medical platform, SCAPE serves as a bridge between the medical communities of China and the U.S., promoting innovation in medical technology and facilitating close cooperation in clinical practice, research, and medical entrepreneurship.

A global leader in stem cell and gene immunotherapy

Beverly Hills Stem Cell & Immunotherapy Group is a globally leading medical institution specializing in stem cell and gene immunotherapy. The center focuses on the research and application of cutting-edge biotechnology, maintaining a world-leading position in regenerative medicine and precision healthcare. Its advancements in stem cell research and gene immunotherapy have provided new directions and hope for the treatment of major diseases, particularly achieving groundbreaking progress in the treatment of neurodegenerative diseases, cancer, and immune system disorders.

One of the largest nonprofit healthcare systems in the United States

CommonSpirit Health operates over 140 hospitals and more than 1,000 care sites, employing 25,000 physicians and 150,000 staff members across 21 states. Under the leadership of former CEO Lloyd H. Dean, the organization fostered innovative partnerships, enhanced patient experiences, and improved healthcare service efficiency, all aimed at building healthier communities. In recognition of Dean's contributions to improving the quality of life for underserved populations, CommonSpirit Health established the Lloyd H. Dean Institute for Humankindness & Health Justice. The institute focuses on health justice initiatives, leveraging the power of humankindness to address health disparities and provide high-quality, equitable healthcare services to diverse communities.

Driven by scientific innovation, focusing on the forefront of regenerative medicine

The Hong Kong Institute for Advanced Study will serve as the primary platform for Sun Yat-sen University's international education initiatives. It aims to focus on cutting-edge interdisciplinary fields and prioritize the establishment of three key platforms: the Biomedical Research Center, the Applied Mathematics Research Center, and the Humanities and Social Sciences Interdisciplinary Research Center. The institute's core mission is to attract top global talents, including Nobel Laureates, Turing Award recipients, and Fields Medalists, to establish world-class laboratories. It seeks to create optimal conditions for the development and application of advanced technologies while independently cultivating high-level innovative talent.

Specializing in the research, development, production, and sales of medical foods, dietary supplements, nutritional products, and health foods.

ALMIL Nutritional Products, Inc., founded in 1983 and headquartered in Brea, California, has developed a range of NMN (Nicotinamide Mononucleotide) products over its four decades of operation. The company holds comprehensive licenses and adheres to Good Manufacturing Practices (GMP), ensuring the quality and safety of its products.

Advancing global standards in transfusion medicine and therapy

The American Association of Blood Banks (AABB), established in 1947, is a globally recognized authority in transfusion medicine and cell therapy standards. As an international nonprofit organization, AABB advances the field by setting and promoting the highest standards in transfusion medicine, driving progress and improving safety in transfusion and cell therapy worldwide.

A leading hub for biomedical and cancer treatment advancements in the United States

America Diagnosis INC is dedicated to providing diagnostic tools and biomarkers to improve the detection and management of cancer and other critical diseases. Its core technologies are based on proprietary protein expression systems and an innovative fluorescence labeling system for detecting multiple tumor markers.

The company’s strengths lie in its team of advanced biomedical scientists, renowned advisors, and experienced executives. It focuses on developing and commercializing innovative in vitro diagnostic products, empowering healthcare professionals to deliver more personalized patient care.

A pioneer in medical innovation and technological advancement.

Under the leadership of Director Lin Hsin-Jung, Hualien Tzu Chi Medical Center has become a global model of medical innovation. The center has made significant strides in integrating traditional Chinese medicine (TCM) with modern Western medicine into comprehensive treatment approaches. It actively advances precision medicine, modern applications of herbal medicine, integrative treatment models, cell therapy technologies, and intranasal drug delivery techniques.

Notably, the center has achieved groundbreaking progress in the treatment and research of major diseases such as Parkinson's disease and amyotrophic lateral sclerosis (ALS), demonstrating exceptional scientific research capabilities and medical service excellence.

The most influential institution for Chinese medicine education and research in Hong Kong

The School of Chinese Medicine at Hong Kong Baptist University is one of the most influential institutions for Chinese medicine education and research in Hong Kong. It is dedicated to modernizing and internationalizing traditional Chinese medicine (TCM). As one of the first TCM schools established in the region, it has made significant achievements in education, research, and clinical practice, integrating modern medical technologies to innovate and expand TCM applications locally and globally.

Through international collaborations and cutting-edge research, the school has become a key driver in the modernization and global development of TCM.

These partnerships enable us to integrate the most advanced medical technologies with global resources, providing patients with internationally standardized treatment solutions.

Includes Bauhinia Health Culture Company as the strategic planner and macro-level guide, along with AI resources led by Peng Shaoliang and his national platform and team

As the strategic planner and macro-level guide, Bauhinia Health Culture Company possesses extensive industry resources and a wide-reaching international influence. A subsidiary of Bauhinia Group, the company demonstrates strong comprehensive capabilities in the health and traditional Chinese medicine (TCM) industries. It integrates top-tier TCM resources from both domestic and international sources, including renowned TCM masters, academicians, and distinguished experts.

Through close collaboration with the National Administration of Traditional Chinese Medicine and leading TCM research institutions, Bauhinia Group has established significant advantages in TCM policies, research, and practice.

The "Bauhinia International TCM Summit" is a flagship event in the TCM field, organized by Bauhinia Group to foster the globalization of TCM and promote the integration of industry, academia, and research. The summit invites TCM experts, university scholars, industry leaders, and investment representatives to discuss cutting-edge topics in TCM development and showcase modern achievements.

The event also features academic forums, free consultations by renowned physicians, and TCM experiential activities, enhancing TCM's global influence and promoting its international expansion.

Through these initiatives, Bauhinia Group highlights the latest achievements in blending TCM's traditional wisdom with modern technology, showcasing its leadership and innovative capabilities in the TCM field.